Neutral and cationic series of new trimeric b-hydroxy amino or ammonium surfactants were synthesized via a two-step process involving the Williamson etherification and regioselective oxirane ring opening with primary and tertiary amines, which afforded good to excellent yields. The synthesized compounds were obtained in high purity by a simple purification procedure on column chromatography. The critical micelle concentration (CMC), effectiveness of surface tension reduction (c CMC ), surface excess concentration (C), and area per molecule at the interface (A) were determined and values indicate that the cationic series is characterized by good surface-active and self-aggregation properties. The antimicrobial activities are reported for the first time against representative bacteria and fungi for trimeric compounds. The antimicrobial potency was found to be dependent on the target microorganism (Gram-positive bacteria [ fungi [ Gram-negative bacteria), as well as both the neutral or ionic nature (cationic [ neutral) and alkyl chain length (tri-C 12 [ tri-C 18 [ tri-C 8 ) of the compounds. The tri-C 8 and tri-C 18 compounds were found to be almost inactive and the tri-C 12 compounds, the most potent antimicrobial surface-active agents from the synthesized series. The trimeric C 12 cationic compound was found to be comparable to benzalkonium chloride against Gram-positive bacteria and fungi, in vitro. The antimicrobial effectiveness of this new compound and the facile two-step procedure for synthesizing it with an excellent overall yield (92%) provide a cost effective trimeric gemini surfactant.

No abstract

The antibiotic susceptibility profile was evaluated in 71 Enterobacteriaceae isolates obtained from outpatient urine cultures in July 2010 from two health institutions in Santa Fe, Argentina. The highest rates of antibiotic resistance were observed for ampicillin (AMP) (69%), trimethoprim/sulfamethoxazole (TMS) (33%), and ciprofloxacin (CIP) (25%). Meanwhile, 21% of the isolates were resistant to three or more tested antibiotics families. Thirty integron-containing bacteria (42.3%) were detected, and a strong association with TMS resistance was found. Third generation cephalosporin resistance was detected in only one Escherichia coli isolate, and it was characterized as a bla CMY-2 carrier. No plasmid-mediated quinolone resistance (PMQR) was found. Resistance to fluoroquinolone in the isolates was due to alterations in QRDR regions. Two mutations in GyrA (S83L, D87N) and one in ParC (S80I) were observed in all CIP-resistant E. coli. It was determined to be the main phylogenetic groups in E. coli isolates. Minimum Inhibitory Concentration (MIC) values against nalidixic acid (NAL), levofloxacin (LEV), and CIP were determined for 63 uropathogenic E. coli isolates as MIC50 of 4 μg/mL, 0.03125 μg/mL, and 0.03125 μg/mL, respectively, while the MIC90 values of the antibiotics were determined as 1024 μg/mL, 64 μg/mL, and 16 μg/mL, respectively. An association between the phylogenetic groups, A and B1 with fluoroquinolone resistance was observed. These results point to the importance of awareness of the potential risk associated with empirical treatment with both the families of antibiotics.

No abstract

No abstract